Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03027427 · ClinicalTrials.gov registry record
Prospective Evaluation and Molecular Profiling in People With Gastric Tumors
A clinical trial of Stomach Cancer and Stomach Neoplasms, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 109
- Enrollment target
- 1
- Study location
NCT03027427 is a study of Stomach Cancer and Stomach Neoplasms that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 109 participants, below the 628-participant average among 15 other Stomach Cancer trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03027427, a study of Stomach Cancer and Stomach Neoplasms, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Certain stomach cancers are rare, but they have high mortality rates. Researchers want to learn more about gastric (stomach) tumors. In this study, they want to collect data from people who have stomach cancer or are at risk to get it. This data will be used to see if the people can be in other studies. Objective: To study tissue from stomach tumors and find people eligible for more studies on gastric cancer. Eligibility: Age greater than or equal to 2 years old who have or may have stomach cancer, lesions that may be related to stomach cancer, or an inherited disorder that leads to stomach cancer. Design: Participants will be screened with: Medical history Physical exam Blood and urine tests Heart tests Scans or ultrasound. For the scans, participants lie in a machine that takes pictures. For some scans, they will swallow or be injected with a small amount of radioactive material. Special cameras will show the material in the body. Tumor sample taken with a needle or surgery Some participants will have an endoscopy. A long, flexible tube with a camera will be inserted through the mouth into the stomach. The tube will collect tissue from the stomach. Some participants may have follow-up visits. Some may be invited to join other studies. Others will be contacted by phone to see how they are doing. ...
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2024-11-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03027427
The ClinicalTrials.gov registry entry for NCT03027427 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 628-participant average among 15 other Stomach Cancer trials with a reported enrollment target (83% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stomach Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03027427 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03027427 about?
NCT03027427 is a clinical study titled "Prospective Evaluation and Molecular Profiling in People With Gastric Tumors". Background: Certain stomach cancers are rare, but they have high mortality rates. Researchers want to learn more about gastric (stomach) tumors. In this study, they want to collect data from people who have stomach cancer or are at risk to get it. This data will be used to see if the people can be ...
What is the current status of trial NCT03027427?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2017-02-01. Estimated completion is 2024-11-06.
What conditions does trial NCT03027427 study?
This clinical trial studies the following conditions: Stomach Cancer, Stomach Neoplasms.
Who is sponsoring clinical trial NCT03027427?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03027427 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stomach Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
RECRUITING · Phase 2
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Avutometinib and Defactinib in Diffuse Gastric Cancer
RECRUITING · Phase 2
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
-
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.